Market data on the venture debt, growth credit and other growth lending deals financing the world’s most innovative companies in September 2026.
Published
Deals tracked53Spanning venture debt, growth credit & other forms of growth lending
Total disclosed financing$2.25bnAcross the 41 of 53 deals that disclosed an amount, in US dollars
Based on deals tracked, discovered or announced during September; financing may have completed earlier.
Three takeaways
1
Growth credit accounted for most of the activity.
Growth credit represented 30 of the 53 announcements tracked by Undiluted, accounting for $1.66bn — roughly 74% of the month’s disclosed financing value.
2
Two large deals accounted for around 38% of disclosed value.
Bird’s $450m financing and Intellia Therapeutics’ facility of up to $400m together account for roughly 38% of the report’s $2.25bn total. A small number of large facilities therefore had a substantial influence on the headline figure.
3
Europe led by deal count; North America led by disclosed value.
European borrowers accounted for 26 tracked announcements, compared with 19 in North America. North America recorded the larger disclosed financing total: approximately $1.24bn, compared with Europe’s $950m.
01
The financing mix
September’s deal announcements, grouped by financing type. Select a category to explore the deals.
Amount disclosedNot disclosed
Aggregate values in US dollars, converted at approximate rates.
02
Where was activity concentrated?
Deals by borrower location, sector and lender type, within Undiluted’s tracked activity. Not a measure of global market share.
Regions are mutually exclusive. Geography follows the borrower.
Deals by lender type
One lender mix per deal. Syndicated deals are counted once.
03
Deal highlights
Four deals we think are worth reading more about.
Bird closes a $450m growth credit package
J.P. Morgan led a seven-bank package of a $400m term loan and a $50m revolver, structured as a dividend recap. Proceeds go to shareholders, including staff with equity, rather than into growth.
OrbiMed commits up to $400m for Intellia Therapeutics
The Nasdaq-listed CRISPR company drew $75m at closing under a five-year senior secured loan, with further tranches tied to FDA approval and launch revenue for its hereditary angioedema therapy.
Voi swaps high-yield bonds for €150m of bank credit
One of Europe’s largest micromobility operators is redeeming its Nordic high-yield bonds with a bank revolver, a sign of scale-ups graduating to cheaper, more flexible senior debt.
Stifel provides Quartermaster with $40m of venture debt
The Virginia maritime intelligence company paired the facility with $100m of Series B equity led by Insight Partners, taking the full package to $140m as it expands SmartMast deployments.
Get the deals behind next month’s deal tracker as they’re announced.
The Stack is our fortnightly briefing on venture debt and growth credit. Subscribers also get each new Deal Tracker when it publishes.
04
Explore all the deals
Every eligible record in the September deal tracker. Click to open a row for more detail.
53 deals
September 2026 announcements
Lender(s)
Country
Category
Details
Commerzbank, KfWBank, Public / development lender
Germany
Growth credit
€15.0M
+
SG Credit Partners, Wingspire CapitalPrivate credit fund
United States
Growth credit
$25.0M
+
Hercules CapitalVenture / growth lending fund
United States
Growth credit
Up to $185.0M
+
Hercules CapitalVenture / growth lending fund
United States
Growth credit
Undisclosed
+
Danske Bank, Swedbank, DNB BankBank
Sweden
Growth credit
€150.0M
+
SwedbankBank
Sweden
Growth credit
Up to SEK 80.0M
+
Stifel Venture BankingBank
United States
Venture debt
$40.0M
+
BNP ParibasBank
France
Growth credit
€12.5M
+
SEB Baltic Venture DebtBank
Lithuania
Venture debt
€1.0M
+
BlackRock Growth LendingVenture / growth lending fund
United Kingdom
Venture debt
Up to $25.0M
+
European Investment BankPublic / development lender
Colombia
Growth credit
€15.0M
+
J.P. Morgan Innovation Economy, Capital One, Citi Digital Venture BankingBank
Netherlands
Growth credit
$450.0M
+
Sort
Showing 12 of 53
05
Methodology
How deals are dated, counted and valued.
Dates
+−
Deals are assigned to the month they were first tracked, discovered or announced. A financing signed in June and first tracked in September counts in September. A deal announced in June and recirculated in September does not count again.
Financing types
+−
Venture debt: Debt for venture-backed companies, usually provided alongside or between equity rounds by specialist lenders or banks, often with warrants. Includes term loans and growth-stage venture loans.
Growth credit: Credit for scaling companies that is sized against revenue, receivables or other assets rather than the last equity round. Includes revolving, asset-backed and receivables facilities.
Other growth financing: Debt-like growth funding outside the two core categories, such as corporate bank loans, revenue-based financing and convertible loans. Only separately disclosed debt portions count.
Currency conversion
+−
Aggregate values are shown in US dollars, converted at approximate rates at the time of announcement. Deal details keep the original currency amount.
Regions, sectors and lender types
+−
Geography follows the borrower’s location.
Each deal is counted once, by the type of lender behind it: funds, banks or public lenders. Deals with more than one type of lender are shown as mixed.
Data sources and corrections
+−
Undiluted maps and tracks the global venture debt and growth lending market. Deals are identified through Undiluted’s own monitoring, regulatory and financial filings, announcements and press releases, and lenders, borrowers and others notifying Undiluted directly.
NewsletterThe Stack
Fortnightly global venture debt & growth credit news — straight to your inbox.
Regular deal coverage between reports, plus each Deal Tracker when it’s published.